Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Quentin30on Dec 07, 2022 9:58am
116 Views
Post# 35155957

RE:RE:RE:RE:what is a barking dog?

RE:RE:RE:RE:what is a barking dog? In the past Lesalpes29, I've given assessments for what I think would be sales prices for Pela, taking into account the price of CPI alone. And trying to have a reasoned discussion only ends up with the pumpers crying... basher... so I won't bother with that again

... and if by bashing, you actually mean questioning our (common) investment, then yeah, eat your heart out I'm a basher.

I don't need to bash, just listen to Matt Coffey in 2018, saying how Aware-1 would be complete in a few months... then in a fireside chat in 2020 (may have been 2021) saying that they would be antiicipating approval by 2024. Then you just need to ask yourself a few questions, what with all the pumpers saying how this company is really worth billions, why in it's 23 year history is the stock down 96%? Why is it that for 10 years ONCY has been repeating the mantra of finding a partner and yet still doesn't have one. Why when posters are finally released with final final Aware-1 data, is the stock still down..

I don't need to bash, the company valuation and lack of interest does that... there are better places to invest quite frankly... this is heading back to support without real news, and that is around $1.30 a share... but, by all means, pump pump pump and fill ya boots at this level... after 20 years of watching this sh*^ show unfold, I could be wrong.


<< Previous
Bullboard Posts
Next >>